SCHEMBL2565637

SCHEMBL2565637

O=S(=O)(Nc1ccncc1)c1cccnc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.64
NFE2L2 Q16236 1/20 0.64
KMT2A Q03164 4/20 0.59
MEN1 O00255 2/20 0.59
ALDH1A1 P00352 4/20 0.57
SNCA P37840 1/20 0.56
GLO1 Q04760 1/20 0.54
SLC40A1 Q9NP59 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
CKS1B P61024 1/20 0.52
SKP2 Q13309 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
POLB P06746 2/20 0.51
TSHR P16473 2/20 0.51
GAA P10253 2/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KDM4E B2RXH2 1/20 0.50
MAP2K7 O14733 1/20 0.50
MAP2K4 P45985 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784141 0.89 KEAP1 (0.66) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL5609957 0.85 KEAP1 (0.59) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL5015931 0.85 KEAP1 (0.68) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL29118864 0.85 KEAP1 (0.65) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL30676966 0.85 KEAP1 (0.65) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL1990223 0.83 KEAP1 (0.73) KEAP1KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL7856929 0.81 KEAP1 (0.63) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL15314389 0.81 KMT2A (0.65) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL5330736 0.81 ALDH1A1 (0.64) KEAP1NFE2L2KMT2AMEN1ALDH1A1
SCHEMBL11655582 0.80 SNCA (0.60) KEAP1NFE2L2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382215-A1 DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-11-02 EP disclosed
WO-2010076525-A1 DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-07-08 WO disclosed